Stocktoria
MapLight Therapeutics, Inc. MPLT
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2025-10-27
Chart by TradingView
3/9
Piotroski F — financial health
—
Altman Z″ — distress risk
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 |
|---|---|---|
| Financials | ||
| Operating income | -$169.1M | -$82.9M |
| Net income | -$161.2M | -$77.6M |
| Operating cash flow | -$138.1M | -$78.8M |
| Free cash flow | -$138.6M | -$79.6M |
| Total assets | $479.5M | $136.9M |
| Total liabilities | $21.1M | $21.7M |
| Shareholders' equity | $458.4M | -$193.6M |
| Ratios | ||
| Return on assets | -33.6% | -56.7% |
| Return on equity | -35.2% | 40.1% |
| Current ratio | 20.01 | 7.20 |
Why these scores methodology →
Piotroski F-score: 3/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: n/a
Not applicable (financials/insurer or missing inputs).
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001770069 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.